Lannett announced it has received approval from the Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Oxycodone HCl Oral Solution, the equivalent of Lehigh Valley Technologies’ listed reference.
Oxycodone HCl is an opioid narcotic indicated for moderate to moderately severe pain. Oxycodone HCl is a pure agonist opioid that has multiple actions qualitatively similar to those of morphine. The most prominent of these involves the central nervous system and organs composed of smooth muscle.
Oxycodone HCl Oral Solution will be available soon as a 100mg/5mL strength.
For more information call (215) 333-9000 or visit Lannett.com.